Published in Postgrad Med J on March 01, 1996
Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study. Lancet (1989) 5.82
End of the New Zealand asthma mortality epidemic. Lancet (1995) 4.88
The human pharmacology of fluticasone propionate. Respir Med (1990) 3.50
Effects of various inhalation modes on the deposition of radioactive pressurized aerosols. Eur J Respir Dis Suppl (1982) 3.08
Factors influencing the size distribution of aerosols from jet nebulisers. Thorax (1983) 2.59
Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered-dose inhaler P-MDI. Eur Respir J (1994) 2.19
Lung deposition patterns of directly labelled salbutamol in normal subjects and in patients with reversible airflow obstruction. Thorax (1993) 1.87
A comparison of fluticasone propionate, 1 mg daily, with beclomethasone dipropionate, 2 mg daily, in the treatment of severe asthma. International Study Group. Eur Respir J (1993) 1.84
Volumatic usage: some generic salbutamol metered dose inhalers can be used. Thorax (1994) 1.76
Standardization of inhalation provocation tests: influence of nebulizer output, particle size, and method of inhalation. J Allergy Clin Immunol (1981) 1.66
Improvement of drug delivery with a breath actuated pressurised aerosol for patients with poor inhaler technique. Thorax (1991) 1.65
Optimal delivery of aerosols from metered dose inhalers. Chest (1981) 1.59
Relative bioavailability of salbutamol to the lung following inhalation using metered dose inhalation methods and spacer devices. Thorax (1994) 1.58
Delivery of beclomethasone dipropionate from a spacer device: what dose is available for inhalation? Thorax (1994) 1.56
Deposition and clinical efficacy of terbutaline sulphate from Turbuhaler, a new multi-dose powder inhaler. Eur Respir J (1989) 1.43
Nebuliser performance, pharmacokinetics, airways and systemic effects of salbutamol given via a novel nebuliser delivery system ("Ventstream"). Thorax (1994) 1.38
Deposition and fate of aerosolized drugs. Chest (1978) 1.29
Pressurized aerosol inhaler technique: how important are inhalation from residual volume, inspiratory flow rate and the time interval between puffs? Br J Dis Chest (1983) 1.28
Aerosol inhalation and depth of deposition in the human lung. The effect of airway obstruction and tidal volume inhaled. Arch Environ Health (1977) 1.19
Pressurised aerosol deposition in the human lung with and without an "open" spacer device. Thorax (1989) 1.17
Deposition of inhaled aerosols. Arch Intern Med (1973) 1.07
Wastage of drug from nebulisers: a review. J R Soc Med (1987) 1.06
Nebulizers--fill volume, residual volume and matching of nebulizer to compressor. Respir Med (1995) 1.02
Prescribed drug therapy and near-fatal asthma attacks. Eur Respir J (1994) 1.00
Production of therapeutic aerosols; principles and techniques. Chest (1981) 0.99
Liposomes for controlled delivery of drugs to the lung. Thorax (1992) 0.97
Clinical evaluation of CFC-free metered dose inhalers. J Aerosol Med (1995) 0.90
Comparison of terbutaline and placebo from a pressurised metered dose inhaler and a dry powder inhaler in a subgroup of patients with asthma. Thorax (1994) 0.90
Medihaler therapy for bronchial asthma; a new type of aerosol therapy. Postgrad Med (1956) 0.89
Neural mechanisms in asthma. Br Med Bull (1992) 0.88
Enhanced responses to aerosolized bronchodilator therapy in asthma using respiratory maneuvers. Chest (1979) 0.87
Metered-dose inhalers and CFCs: what respiratory physicians need to know. Respir Med (1994) 0.87
A new baby-spacer device for aerosolized bronchodilator administration in infants with bronchopulmonary disease. Eur J Pediatr (1992) 0.87
Safety of propellants. J Aerosol Med (1995) 0.84
A multicentre comparison of the efficacy of terbutaline Turbuhaler and salbutamol pressurized metered dose inhaler in hot, humid regions. Eur Respir J (1994) 0.80
Clinical pharmacology of HFA134a. J Aerosol Med (1995) 0.80
Generic salbutamol metered dose inhalers. Thorax (1995) 0.77
A nebulizer system for highly reproducible aerosol delivery. J Aerosol Med (1994) 0.77
Propellant-powered nebulizers. J Am Pharm Assoc (1976) 0.76
A mechanical micro spray pump: an alternative to propellant driven devices? J Aerosol Med (1994) 0.76
Feasibility of a low dosage dynamic powder dispenser for drug delivery to the lungs. J Aerosol Med (1994) 0.76
Deposition of pressurized suspension aerosols inhaled through extension devices. Am Rev Respir Dis (1981) 4.16
Deposition of pressurised aerosols in the human respiratory tract. Thorax (1981) 3.73
Effect of lung function and mode of inhalation on penetration of aerosol into the human lung. Thorax (1977) 3.35
Improvement of pressurised aerosol deposition with Nebuhaler spacer device. Thorax (1984) 3.30
Effects of various inhalation modes on the deposition of radioactive pressurized aerosols. Eur J Respir Dis Suppl (1982) 3.08
Sudden death in asthma. Thorax (1979) 2.72
Reliability of eliciting physical signs in examination of the chest. Lancet (1988) 2.71
Factors influencing the size distribution of aerosols from jet nebulisers. Thorax (1983) 2.59
How should a pressurized beta-adrenergic bronchodilator be inhaled? Eur J Respir Dis (1981) 2.41
Anti-tuberculosis medication and the liver: dangers and recommendations in management. Eur Respir J (1995) 2.39
Emergency tracheostomy. Practitioner (1975) 2.18
Use of expandable metal stents in the treatment of bronchial obstruction. Thorax (1989) 2.07
Inhalation therapy in asthma. J R Soc Med (1992) 2.01
Assessment of jet nebulisers for lung aerosol therapy. Lancet (1983) 1.99
Effects of sputum on pulmonary function. Br Med J (1977) 1.94
Droplet size distributions of nebulised aerosols for inhalation therapy. Clin Phys Physiol Meas (1986) 1.87
Evaluation of jet nebulisers for use with gentamicin solution. Thorax (1985) 1.85
Factors contributing to the reversible pulmonary hypertension of patients with acute respiratory failure studies by serial observations during recovery. Circ Res (1969) 1.77
The normal and abnormal pancreatic scan. Q J Med (1968) 1.74
Bone disease and calcium absorption in primary biliary cirrhosis with special reference to vitamin-D therapy. Lancet (1968) 1.67
Improvement of drug delivery with a breath actuated pressurised aerosol for patients with poor inhaler technique. Thorax (1991) 1.65
Deposition and clearance of inhaled particles. Bull Eur Physiopathol Respir (1980) 1.61
Bronchodilator delivery from Gentlehaler, a new low-velocity pressurized aerosol inhaler. Chest (1993) 1.60
Resistance to two-phase gas-liquid flow in airways. J Appl Physiol (1970) 1.56
Effect of acute magnesium administration on the frequency of ventricular arrhythmia in patients with heart failure. Circulation (1994) 1.56
Interaction of corticosteroids and catecholamines in the treatment of asthma. Thorax (1975) 1.52
A comparison of biopsy results using rigid and fibreoptic bronchoscopes. Br J Dis Chest (1980) 1.47
Chronic pancreatitis in England: a changing picture? Br Med J (1974) 1.46
Deposition of carbenicillin aerosols in cystic fibrosis: effects of nebuliser system and breathing pattern. Thorax (1988) 1.44
Relation between gender, etiology and survival in patients with symptomatic heart failure. J Am Coll Cardiol (1996) 1.44
Deposition and clinical efficacy of terbutaline sulphate from Turbuhaler, a new multi-dose powder inhaler. Eur Respir J (1989) 1.43
Effect of aerosol particle size on bronchodilatation with nebulised terbutaline in asthmatic subjects. Thorax (1986) 1.42
Delivery of albuterol and ipratropium bromide from two nebulizer systems in chronic stable asthma. Efficacy and pulmonary deposition. Chest (1989) 1.41
Nebulisers: uses and abuses. Arch Dis Child (1986) 1.41
Pancreatic scanning. Br J Radiol (1976) 1.40
Therapeutic aerosols 1--physical and practical considerations. Thorax (1983) 1.36
Selective bronchography using the fibreoptic bronchoscope. Br J Dis Chest (1982) 1.36
Simple instructions for using pressurized aerosol bronchodilators. J R Soc Med (1980) 1.36
Lung mucociliary clearance in patients wit Young's syndrome. Chest (1981) 1.35
Obstructive azoospermia: respiratory function tests, electron microscopy and the results of surgery. Br J Urol (1978) 1.35
Enhanced clearance of secretions from the human lung after the administration of hypertonic saline aerosol. Am Rev Respir Dis (1978) 1.33
Measurement of bronchial mucociliary clearance. Eur J Respir Dis Suppl (1983) 1.33
High incidence of cardiomyopathy in beta-thalassaemia patients receiving regular transfusion and iron chelation: reversal by intensified chelation. Acta Haematol (1990) 1.30
Assessment of the forced expiration technique, postural drainage and directed coughing in chest physiotherapy. Eur J Respir Dis (1983) 1.30
Therapeutic aerosols 2--Drugs available by the inhaled route. Thorax (1984) 1.23
Airways penetration of inhaled radioaerosol: an index to small airways function? Eur J Respir Dis (1981) 1.18
No added benefit from nebulized amiloride in patients with cystic fibrosis. Eur Respir J (1993) 1.18
Pressurised aerosol deposition in the human lung with and without an "open" spacer device. Thorax (1989) 1.17
Beclomethasone dipropionate aerosol in asthma. Transfer of steroid-dependent asthmatic patients from oral prednisone to beclomethasone dipropionate aerosol. Am Rev Respir Dis (1974) 1.17
Radioselenium in duodenal aspirate as an assessment of pancreatic exocrine function. Br Med J (1971) 1.16
High prevalence of low bone mass in thalassaemia major. Br J Haematol (1998) 1.15
The effect of expiratory flow rate on regional lung emptying. Clin Sci (1969) 1.15
Is cough as effective as chest physiotherapy in the removal of excessive tracheobronchial secretions? Thorax (1981) 1.14
A technique for monitoring the inhalation of cigarette smoke in man, using krypton-81m. Int J Appl Radiat Isot (1980) 1.13
An analysis of the first 300 fibreoptic bronchoscopies at the Brompton Hospital. Br J Dis Chest (1979) 1.11
Assessment of the 14C-glycocholic acid breath test. Br Med J (1973) 1.11
Effect of ipratropium bromide on mucociliary clearance and pulmonary function in reversible airways obstruction. Thorax (1979) 1.10
Domiciliary humidification improves lung mucociliary clearance in patients with bronchiectasis. Chron Respir Dis (2008) 1.10
Pulmonary function in inflammatory bowel disease. Digestion (1978) 1.08
Assessment of percussion, vibratory-shaking and breathing exercises in chest physiotherapy. Eur J Respir Dis (1985) 1.08
Impaired tracheobronchial clearance in patients with mild stable asthma. Thorax (1983) 1.08
Value of hypotonic duodenography as an adjunct to pancreatic scanning. Gut (1969) 1.07
Comparison of three isotopic methods for the study of calcium absorption. Gut (1969) 1.07
Wastage of drug from nebulisers: a review. J R Soc Med (1987) 1.06
Metabolic response to intravenous salbutamol therapy in acute asthma. Thorax (1977) 1.04
Phenotypic and functional changes in alveolar macrophages contribute to the pathogenesis of pulmonary sarcoidosis. Clin Exp Immunol (1988) 1.03
The retention of lung secretions during the night in normal subjects. Clin Sci Mol Med Suppl (1978) 1.03
Techniques for measuring lung mucociliary clearance. Eur J Respir Dis Suppl (1980) 1.02
Chest physiotherapy: a review. Eur J Respir Dis (1982) 1.02
The effect of oral aminophylline on lung mucociliary clearance in man. Chest (1981) 1.02
A comparative study of four tests of pancreatic function in the diagnosis of pancreatic disease. Q J Med (1973) 1.02
Rational sequence of tests for pancreatic function. Br Med J (1976) 1.01
47 Calcium abosrption in parenchymatous and biliary liver disease. Gut (1971) 1.00
Impaired tracheobronchial clearance in bronchiectasis. Thorax (1987) 0.99
Aerosolised pentamidine. Lancet (1989) 0.99
Variability and reproducibility in the measurement of tracheobronchial clearance in healthy subjects and patients with different obstructive lung diseases. Eur Respir J (1988) 0.98
Regional lung clearance of excessive bronchial secretions during chest physiotherapy in patients with stable chronic airways obstruction. Lancet (1979) 0.98
Effect of InspirEase on the deposition of metered-dose aerosols in the human respiratory tract. Chest (1986) 0.98
High incidence of osteoporosis in thalassaemia major. J Pediatr Endocrinol Metab (1998) 0.97
Choice of nebulisers and compressors for delivery of carbenicillin aerosol. Eur J Respir Dis (1986) 0.97
Alveolar macrophages that suppress T-cell responses may be crucial to the pathogenetic outcome of pulmonary sarcoidosis. Eur Respir J (1992) 0.96
Quantitative comparison of 99Tcm-aerosol and 81Krm ventilation images. Clin Phys Physiol Meas (1982) 0.95
Transbronchial lung biopsy through the fibreoptic bronchoscope. Br J Dis Chest (1978) 0.95
Lung mucus production and mucociliary clearance: methods of assessment. Br J Clin Pharmacol (1980) 0.94
Primary pulmonary hypertension: a case report including electronmicroscopic study. Br J Dis Chest (1974) 0.94
Inhaled corticosteroids can modulate the immunopathogenesis of pulmonary sarcoidosis. Eur Respir J (1989) 0.94
The relief of bone pain in primary biliary cirrhosis with calcium infusions. Gut (1974) 0.93
Differences between pressurized aerosol and stable dust particles. Chest (1981) 0.93
Mucus clearance from the airways in chronic bronchitis--Smokers and ex-smokers. Bull Eur Physiopathol Respir (1982) 0.93